Supplementary figures Supplementary Figure 1. Western blot of dilution series of rNG-irisin. Recombinant NGirisin was diluted in PBS (lanes 1-8; absolute amounts 20, 4, 2, 1, 0.5, 0.25, 0.125, 0.0625 ng irisin/lane) or bovine plasma (lanes 9-16; irisin amounts as in PBS). Mouse serum is shown in lanes 17 and 18, human serum in lanes 19-24, and mouse muscle protein in lane 25. (a-c) Detection with pAb-B (a), pAb-C (b), and pAb-D (c). Trueblot rabbit HRP was used as detection system. Original images were taken after 10 min of exposure. Linearity of detection of irisin was given for all antibodies in the range between 4 ng/lane and 0.125 ng/lane (R² = 0.9467 for pAb-B; R² = 0.9465 for pAb-C, and R² = 0.9715 for pAb-D). Supplementary Figure 2. Lot-to-lot variability of irisin antibodies. (a, b) Two lots of pAb-A were used to detect irisin in murine serum (lane 1) and muscle (lane 2; Lot # 01478 (a) vs. Lot # 01545 (b)). (c, d) Two lots of pAb-C were used to stain human serum (lanes 1-2) and rNG-irisin as positive control (lane 3; Lot # A25071305 (c) vs. Lot # A25481312 (d)). Supplementary Figure 3. Western blot of equine serum with pAb-C. Serum samples of three horses with metabolic diseases (lanes 1-3), of a horse immediately (lane 4a) and 30 min after (lane 4b) 45 min of moderate exercise. Horses (lanes 5-9) were sampled 10-30 min after participation in a 160 km endurance race (lanes a) and 60 min after the first sample (lanes b). Recombinant NG-irisin was included as positive control (lane 10). M: Molecular weight marker. The image was taken after 30 min exposure.
